In addition, paclitaxel chemotherapy can enhance rapid ECM remodeling and mechano-structural changes by inducing the expression of LOX in CD8+ T cells, subsequently improving the invasion and metastasis of breast cancer cells in the lung [135]. Here, LOX is linked to breast carcinoma.